Medical exoskeleton market expected to grow significantly due to advancements in technology and increasing demand.

From GlobeNewswire: 2025-07-02 10:02:00

The Global Medical Exoskeleton Market is set to reach USD 538.4 Mn in 2025 and is projected to hit USD 2,267.2 Mn by 2032, with a CAGR of 22.8%. These wearable systems assist individuals with mobility challenges, with the lower body segment dominating at 43.2% in 2025. North America leads in market share, with Europe and Asia Pacific showing promising growth.

The rising prevalence of disabilities and neurological disorders is driving market growth, with over 3 billion people worldwide living with neurological conditions. High costs and regulatory hurdles are limiting market expansion, as advanced medical exoskeletons are expensive and face rigorous approval processes.

Innovations in AI, IoT, sensors, and lightweight materials are creating growth opportunities, enhancing the functionality and adaptability of medical exoskeletons. AI technology is transforming exoskeletons into intelligent companions, anticipating user intentions and reducing fall risk, particularly in rehabilitation settings.

Emerging trends include an increasing geriatric population, rising spinal cord injuries, a shift to mobile exoskeletons, and a focus on developing exoskeletons for home care settings. Companies are innovating to meet evolving needs and preferences while improving the overall quality of life for individuals with mobility challenges.

Recent events, such as the U.S. Department of Veterans Affairs expanding exoskeleton coverage and breakthroughs in exoskeleton technologies, are expected to increase accessibility and fuel market growth. The implementation of the EU’s AI Act will bring strict regulatory scrutiny to AI-integrated exoskeletons, ensuring compliance with transparency and safety criteria.

Key companies in the market include BIONIK, ReWalk Robotics, Ekso Bionics, Suit X, PARKER HANNIFIN CORP, Rex Bionics Ltd, B-Temia, CYBERDYNE INC, ExoAtlet, and Wandercraft. Ongoing developments, such as Lifeward Ltd.’s U.S. launch of the ReWalk 7 Personal Exoskeleton and Wandercraft’s clinical trial for the Personal Exoskeleton, highlight the continuous advancements in the industry.



Read more at GlobeNewswire: Medical Exoskeleton Market Poised for Growth, Estimated to